Percheron Therapeutics Limited (ASX:PER)

Percheron Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Operating Revenue	2.97	2.97	1.96	-	-	-
Other Revenue	-1.05	-	-	1.78	0.58	0.67
Revenue	1.92	2.97	1.96	1.78	0.58	0.67
Revenue Growth (YoY)	-28.14%	51.07%	10.51%	207.72%	-13.56%	13.91%
Cost of Revenue	0.12	0.06	0.03	0.07	0.11	0.2
Gross Profit	1.8	2.91	1.93	1.71	0.47	0.46
Selling, General & Admin	4.11	3.84	2.84	2.8	2.18	2.04
Research & Development	12.74	10.7	10.16	4.54	4.91	1.9
Operating Expenses	17.44	14.82	13.31	7.55	8.57	6.46
Operating Income	-15.63	-11.91	-11.38	-5.83	-8.11	-6
Interest Expense	-0.01	-0	-0.01	-0.01	-0.01	-0.01
Interest & Investment Income	-	-	-	0.03	0	0.03
Currency Exchange Gain (Loss)	-0.07	-0	0.01	-0	-0	-0
EBT Excluding Unusual Items	-15.71	-11.92	-11.38	-5.81	-8.12	-5.98
Other Unusual Items	-	-	-	-	0.05	0.07
Pretax Income	-15.71	-11.92	-11.38	-5.81	-8.06	-5.91
Net Income	-15.71	-11.92	-11.38	-5.81	-8.06	-5.91
Net Income to Common	-15.71	-11.92	-11.38	-5.81	-8.06	-5.91
Shares Outstanding (Basic)	985	881	669	634	541	456
Shares Outstanding (Diluted)	985	881	669	634	541	456
Shares Change (YoY)	41.43%	31.74%	5.45%	17.25%	18.68%	18.06%
EPS (Basic)	-0.02	-0.01	-0.02	-0.01	-0.01	-0.01
EPS (Diluted)	-0.02	-0.01	-0.02	-0.01	-0.01	-0.01
Free Cash Flow	-13.84	-10.12	-8.18	-7.81	-5.84	-3.96
Free Cash Flow Per Share	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Gross Margin	93.99%	97.91%	98.32%	96.31%	80.91%	69.51%
Operating Margin	-814.29%	-401.32%	-579.21%	-328.10%	-1402.91%	-897.30%
Profit Margin	-818.38%	-401.57%	-579.19%	-326.89%	-1395.14%	-883.89%
Free Cash Flow Margin	-721.02%	-340.93%	-416.36%	-439.23%	-1011.23%	-591.77%
EBITDA	-15.63	-11.9	-11.37	-5.83	-8.1	-5.99
D&A For EBITDA	0	0.01	0.01	0.01	0.01	0
EBIT	-15.63	-11.91	-11.38	-5.83	-8.11	-6
Revenue as Reported	-	-	-	1.81	0.64	0.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.